AstraZeneca PLC's Fiscal Year is From January To December.
The item "Receivables-Turnover" stands at 4.17 as of 09/30/2025.
As of the end of AstraZeneca PLC's third quarter, the item "Receivables Turnover" stands at 4.17. This represents an increase of 0.65 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.8955 percent compared to the value the year prior.
The 1 year change in percent is 0.8955.
The 3 year change in percent is -11.65.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Receivables Turnover | 905,699,262,464.00 |
![]() | Johnson & Johnson - Receivables Turnover | 486,508,953,600.00 |
![]() | AbbVie Inc - Receivables Turnover | 399,570,305,024.00 |
![]() | Roche Holding AG - Receivables Turnover | 317,433,206,677.55 |
![]() | Novartis AG - Receivables Turnover | 255,096,620,580.91 |